Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125496461 | 12549646 | 1 | I | 20160330 | 20160705 | 20160712 | 20160712 | EXP | FR-SA-2016SA124726 | AVENTIS | 87.00 | YR | E | M | Y | 0.00000 | 20160712 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125496461 | 12549646 | 1 | SS | CALCIPARINE | HEPARIN CALCIUM | 1 | Subcutaneous | U | UNKNOWN | 0 | |||||||||
125496461 | 12549646 | 2 | PS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | U | UNKNOWN | 21081 | |||||||||
125496461 | 12549646 | 3 | SS | COUMADINE | WARFARIN SODIUM | 1 | Oral | U | UNKNOWN | 0 | 2 | MG | QD | ||||||
125496461 | 12549646 | 4 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
125496461 | 12549646 | 5 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
125496461 | 12549646 | 6 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
125496461 | 12549646 | 7 | C | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
125496461 | 12549646 | 8 | C | LASILIX | FUROSEMIDE | 1 | 0 | ||||||||||||
125496461 | 12549646 | 9 | C | MIRCERA | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 1 | 0 | ||||||||||||
125496461 | 12549646 | 10 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | 0 | ||||||||||||
125496461 | 12549646 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | ||||||||||||
125496461 | 12549646 | 12 | C | PYOSTACINE | PRISTINAMYCIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125496461 | 12549646 | 1 | Atrial fibrillation |
125496461 | 12549646 | 2 | Diabetes mellitus |
125496461 | 12549646 | 3 | Atrial fibrillation |
125496461 | 12549646 | 4 | Diabetes mellitus |
125496461 | 12549646 | 12 | Erysipelas |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125496461 | 12549646 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125496461 | 12549646 | Anaemia | |
125496461 | 12549646 | Hypoglycaemic seizure | |
125496461 | 12549646 | Rectal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125496461 | 12549646 | 1 | 2015 | 20160329 | 0 | |
125496461 | 12549646 | 3 | 2014 | 20160329 | 0 |